1. Home
  2. HOTH vs PASW Comparison

HOTH vs PASW Comparison

Compare HOTH & PASW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOTH
  • PASW
  • Stock Information
  • Founded
  • HOTH 2017
  • PASW 2021
  • Country
  • HOTH United States
  • PASW Hong Kong
  • Employees
  • HOTH N/A
  • PASW N/A
  • Industry
  • HOTH Biotechnology: Pharmaceutical Preparations
  • PASW Apparel
  • Sector
  • HOTH Health Care
  • PASW Consumer Discretionary
  • Exchange
  • HOTH Nasdaq
  • PASW Nasdaq
  • Market Cap
  • HOTH 18.0M
  • PASW 15.9M
  • IPO Year
  • HOTH 2019
  • PASW N/A
  • Fundamental
  • Price
  • HOTH $1.16
  • PASW $0.52
  • Analyst Decision
  • HOTH Strong Buy
  • PASW
  • Analyst Count
  • HOTH 2
  • PASW 0
  • Target Price
  • HOTH $4.50
  • PASW N/A
  • AVG Volume (30 Days)
  • HOTH 316.4K
  • PASW 48.9K
  • Earning Date
  • HOTH 11-12-2025
  • PASW 01-12-2026
  • Dividend Yield
  • HOTH N/A
  • PASW N/A
  • EPS Growth
  • HOTH N/A
  • PASW N/A
  • EPS
  • HOTH N/A
  • PASW N/A
  • Revenue
  • HOTH N/A
  • PASW $8,286,193.00
  • Revenue This Year
  • HOTH N/A
  • PASW N/A
  • Revenue Next Year
  • HOTH N/A
  • PASW N/A
  • P/E Ratio
  • HOTH N/A
  • PASW N/A
  • Revenue Growth
  • HOTH N/A
  • PASW N/A
  • 52 Week Low
  • HOTH $0.66
  • PASW $0.51
  • 52 Week High
  • HOTH $3.80
  • PASW $5.40
  • Technical
  • Relative Strength Index (RSI)
  • HOTH 38.64
  • PASW N/A
  • Support Level
  • HOTH $1.14
  • PASW N/A
  • Resistance Level
  • HOTH $1.22
  • PASW N/A
  • Average True Range (ATR)
  • HOTH 0.08
  • PASW 0.00
  • MACD
  • HOTH -0.01
  • PASW 0.00
  • Stochastic Oscillator
  • HOTH 38.57
  • PASW 0.00

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).

About PASW Ping An Biomedical Co. Ltd. Ordinary Shares

Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.

Share on Social Networks: